![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1382133
¾È°ú¿ë ¼ö¼ú±â±¸ ½ÃÀå ¸®Æ÷Æ®(2023³â) : ¼¼°è ½ÃÀå ºÐ¼®(2022-2028³â)2023 Ophthalmic Surgical Instruments Market Report: Global Analysis for 2022 to 2028 |
¼¼°è ¾È°ú ¼ö¼ú±â±¸ ½ÃÀåÀÇ ´Ù¾çÇÑ Áö¼Ó°¡´É¼º ±¸»ó°ú ÀÏȸ¿ë ±â±¸·Î ÀÎÇÑ ¼ö¼ú½Ç Æó±â¹°À» ÁÙÀ̱â À§ÇÑ ESCRS¿Í AAOÀÇ ±Ç°í»çÇ׿¡ ´ëÇÑ ÃֽŠÁ¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ »õ·Î¿î Àå¿¡¼´Â Á¦Á¶¾÷ü°¡ Á÷¸éÇÑ °úÁ¦¿¡ ÁÖ¸ñÇϰí, ÀÌ·¯ÇÑ ³ë·ÂÀÌ °¢ Á¦Ç° Ä«Å×°í¸®ÀÇ ¹Ì·¡ ¸ÅÃâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ¿¹ÃøÇÒ ¼ö ÀÖ´Â »õ·Î¿î Æò°¡ ôµµ¸¦ Á¦½ÃÇÕ´Ï´Ù.
¿Ü°úÀû ½Ã¼ú¿¡ ´ëÇÑ ¿¹ÃøÀ» ¾È°ú Àü¹® ºÐ¾ßº° ¿¹Ãø°ú ¿¬°áÇÕ´Ï´Ù. ¶ÇÇÑ ¼¼°è µ¶Á¡Àû °ø±ÞÀÚ¸¦ ź»ý½ÃŲ Ãֽбâ¾÷ Àμö ¹× ÅëÇÕ ¿òÁ÷ÀÓ¿¡ ´ëÇÑ ³»¿ëµµ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
2023³â ±âÁØ ¼¼°è ¾È°ú¿ë ¼ö¼ú±â±¸ ½ÃÀå(Àç»ç¿ë ¹× ÀÏȸ¿ë)¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®°ú ÇâÈÄ 5³â°£ ½ÃÀå ¼º°ú¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä µ¿Çâ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÇâÈÄ ¼º°øÀ» À§ÇÑ ÁÖ¿ä ¿äÀÎÀ» »ìÆìº¾´Ï´Ù. ÀÌ º¸°í¼´Â ¼¼°è ¾È°ú ¼ö¼ú°ú ¼ö¼ú °Ç¼ö¿¡ ´ëÇÑ °³¿ä¿Í °¡Àå ÀϹÝÀûÀ¸·Î ½ÃÇàµÇ´Â ¾È°ú ¼ö¼úÀÎ ¹é³»Àå ¼ö¼úÀÇ ÇÁ·Î¹ÙÀÌ´õ¿¡ ´ëÇØ ÀÚ¼¼È÷ ¼³¸íÇÕ´Ï´Ù. Á¦Ç° ¼ö¿ä´Â ¼ö·®°ú ±Ý¾×À¸·Î ¿¹ÃøµÇ¸ç, ½ÃÀå Á¡À¯À²Àº Á¦Ç° Ä«Å×°í¸®º°·Î ºÐ¼®µË´Ï´Ù. ½ÃÀå ¼¼ºÐÈ¿¡¼´Â Á¦Ç°, Àü·«Àû ½ÃÀå ÁöÀ§, ¹è°æ, Àü¸Á µî 31°³ ±â¾÷ °³¿äÀ» °ÔÀçÇϰí, ½ÃÀå ºÎ¹®¿¡ °ü·ÃµÈ 85°³ ±â¾÷ÀÇ ¸®½ºÆ®°¡ ¼ö·ÏµÇ¾î ÀÖ½À´Ï´Ù.
ÀçÀÌ¿ëÇü¡¤ÀÏȸ¿ë ±â±¸ ½ÃÀå µ¿Çâ¿¡ ´ëÇØ µ¶ÀÚÀÇ ÀÌÇØ¿¡ ±íÀÌ¿Í ¹è°æÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. ³»¿ëÀº ¾Æ·¡¿Í °°½À´Ï´Ù. :
The new "2023 Ophthalmic Surgical Instruments Market Report" provides the latest coverage of various sustainability initiatives and recommendations from the ESCRS and AAO to reduce operating room waste caused by disposable devices. A new chapter on sustainability looks at the challenges that manufacturers face and includes a new rating scale showing the predicted impact of these initiatives on future sales of each product category.
The report connects our surgical procedure forecast by ophthalmic subspecialty to our forecast for surgical instruments. It also lists the latest company acquisitions and consolidations among market competitors that have created globally dominant providers.
The report provides a comprehensive analysis of the 2023 global market for ophthalmic surgical instruments-both reusable and disposable-and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery. Product demand is forecast in units and dollars, and market shares are analyzed by product category. The report profiles 31 market competitors-with discussion of their products, strategic market position, background, and outlook-and lists 85 total companies involved in the market segment.
The report is designed to provide depth and context to the reader's understanding of market dynamics in the reusable and disposable instrument market. Coverage includes:
Bill Freeman has more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.
Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.
CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.
In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company's cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.
Bill remained with Alcon until 1995. He then joined Mentor Ophthalmics as president of the ophthalmology division. At Mentor, he was responsible for the company's ophthalmic products including IOLs, cautery devices, and surgical instruments.
After leaving Mentor in 1999, Bill joined Market Scope in 2000 and now serves as executive vice president focusing on ophthalmic surgical cataract, retinal and glaucoma devices.